PMID- 36537385
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230427
IS  - 2303-9027 (Print)
IS  - 2226-7190 (Electronic)
IS  - 2226-7190 (Linking)
VI  - 11
IP  - 6
DP  - 2022 Nov-Dec
TI  - Feasibility and efficacy of endoscopic reintervention after covered metal stent 
      placement for EUS-guided hepaticogastrostomy: A multicenter experience.
PG  - 478-486
LID - 10.4103/EUS-D-22-00029 [doi]
AB  - BACKGROUND AND OBJECTIVES: Although the use of a long metal stent is favored for 
      EUS-guided hepaticogastrostomy (EUS-HGS) for the relief of malignant biliary 
      obstruction (MBO), endoscopic reintervention (E-RI) at the time of recurrent 
      biliary obstruction (RBO) is challenging due to a long intragastric portion. This 
      study evaluated the feasibility and safety of E-RI after a long partially covered 
      metal stent (L-PCMS) placement during EUS-HGS. MATERIALS AND METHODS: We 
      performed a multicenter retrospective study between January 2015 and December 
      2019 examining patients with MBO who underwent E-RI for RBO through the EUS-HGS 
      route after the L-PCMS placement. Technical and clinical success rates, details 
      of E-RI, adverse events (AEs), stent patency, and survival time were evaluated. 
      RESULTS: Thirty-three patients at eight referral centers in Japan who underwent 
      E-RI through the EUS-HGS route were enrolled. The location of MBO was distal in 
      54.5%. The median intragastric length of the L-PCMS was 5 cm. As the first E-RI 
      attempt, E-RI via the distal end of the existing L-PCMS was successful in 60.6%. 
      The overall technical and clinical success rates of E-RI were 100% and 81.8%, 
      respectively. Liver abscess was noted in one patient. A proximal biliary 
      stricture was associated with the clinical ineffectiveness of E-RI in 
      multivariable analysis (odds ratio, 12.5, P = 0.04). The median survival and 
      stent patency duration after E-RI were 140 and 394 days, respectively. 
      CONCLUSIONS: Our study findings suggest that E-RI for RBO after EUS-HGS with a 
      L-PCMS is technically feasible and clinically effective, without any severe AEs, 
      especially for patients with distal MBO.
FAU - Minaga, Kosuke
AU  - Minaga K
AD  - Department of Gastroenterology and Hepatology, Kindai University Faculty of 
      Medicine, Osaka-Sayama, Japan.
FAU - Kitano, Masayuki
AU  - Kitano M
AD  - Second Department of Internal Medicine, Wakayama Medical University, Wakayama, 
      Japan.
FAU - Uenoyama, Yoshito
AU  - Uenoyama Y
AD  - Department of Gastroenterology, Japan Red Cross Wakayama Medical Center, 
      Wakayama, Japan.
FAU - Hatamaru, Keiichi
AU  - Hatamaru K
AD  - Second Department of Internal Medicine, Wakayama Medical University, Wakayama, 
      Japan.
FAU - Shiomi, Hideyuki
AU  - Shiomi H
AD  - Department of Internal Medicine, Division of Gastroenterology, Kobe University 
      Graduate School of Medicine, Kobe, Japan.
FAU - Ikezawa, Kenji
AU  - Ikezawa K
AD  - Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer 
      Institute, Osaka, Japan.
FAU - Miyagahara, Tsukasa
AU  - Miyagahara T
AD  - Department of Gastroenterology, Nakatsu Municipal Hospital, Nakatsu, Japan.
FAU - Imai, Hajime
AU  - Imai H
AD  - Department of Gastroenterology, Okanami General Hospital, Iga, Japan.
FAU - Fujimori, Nao
AU  - Fujimori N
AD  - Department of Medicine and Bioregulatory Science, Graduate School of Medical 
      Sciences, Kyushu University, Fukuoka, Japan.
FAU - Matsumoto, Hisakazu
AU  - Matsumoto H
AD  - Department of Gastroenterology, Japan Red Cross Wakayama Medical Center, 
      Wakayama, Japan.
FAU - Shimokawa, Yuzo
AU  - Shimokawa Y
AD  - Department of Gastroenterology, Nakatsu Municipal Hospital, Nakatsu, Japan.
FAU - Masuda, Atsuhiro
AU  - Masuda A
AD  - Department of Internal Medicine, Division of Gastroenterology, Kobe University 
      Graduate School of Medicine, Kobe, Japan.
FAU - Takenaka, Mamoru
AU  - Takenaka M
AD  - Department of Gastroenterology and Hepatology, Kindai University Faculty of 
      Medicine, Osaka-Sayama, Japan.
FAU - Kudo, Masatoshi
AU  - Kudo M
AD  - Department of Gastroenterology and Hepatology, Kindai University Faculty of 
      Medicine, Osaka-Sayama, Japan.
FAU - Chiba, Yasutaka
AU  - Chiba Y
AD  - Clinical Research Center, Kindai University Hospital, Osaka-Sayama, Japan.
LA  - eng
PT  - Journal Article
PL  - China
TA  - Endosc Ultrasound
JT  - Endoscopic ultrasound
JID - 101622292
PMC - PMC9921972
OTO - NOTNLM
OT  - EUS
OT  - EUS-guided biliary drainage
OT  - hepaticogastrostomy
OT  - malignant biliary obstruction
OT  - reintervention
COIS- None
EDAT- 2022/12/21 06:00
MHDA- 2022/12/21 06:01
PMCR- 2022/12/05
CRDT- 2022/12/20 06:14
PHST- 2022/12/20 06:14 [entrez]
PHST- 2022/12/21 06:00 [pubmed]
PHST- 2022/12/21 06:01 [medline]
PHST- 2022/12/05 00:00 [pmc-release]
AID - EndoscUltrasound_2022_11_6_478_362657 [pii]
AID - EUS-11-478 [pii]
AID - 10.4103/EUS-D-22-00029 [doi]
PST - ppublish
SO  - Endosc Ultrasound. 2022 Nov-Dec;11(6):478-486. doi: 10.4103/EUS-D-22-00029.